• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.26% Nasdaq Down 0.34%

    Alexion Pharmaceuticals, Inc. (ALXN)

    -NasdaqGS
    186.24 Up 1.02(0.55%) Jul 6, 4:00PM EDT
    |After Hours : 186.05 Down 0.19 (0.10%) Jul 6, 7:00PM EDT
    Add to Portfolio
    Prev Close:185.22
    Open:183.40
    Bid:185.16 x 200
    Ask:193.20 x 200
    1y Target Est:220.00
    Beta:1.44
    Earnings Date:Jul 22 - Jul 27 (Est.)
    Day's Range:182.91 - 187.53
    52wk Range:150.06 - 203.30
    Volume:1,476,796
    Avg Vol (3m):2,149,140
    Market Cap:41.74B
    P/E (ttm):63.80
    EPS (ttm):2.92
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ALXN

    Comparison

    Symbol% ChgMkt Cap
    ALXNUp 0.55%41.74B
    AMGNUp 0.81%117.47B
    BAXDown 0.68%20.68B

    Key Statistics

    Forward P/E (1 yr):31.09
    P/S (ttm):16.30
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :4.98
    Quarterly EPS Est (Jun-15) :1.38
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):2.11

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. It offers Soliris (eculizumab), a therapeutic product to treat paroxysmal nocturnal hemoglobinuria (PNH), a genetic blo... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback